Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series

Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series

Objective: Evidence strongly supports the use of mifepristone-misoprostol combination treatment for early pregnancy loss (EPL) among pregnancies conceived without assisted reproductive technologies. No literature exists, however, regarding the efficacy of this treatment in the medical management of...

Full description

Bibliographic Details
Main Authors:	Leah Esposito, Molly Siegel Kornfield, M.D., Elizabeth Rubin, M.D., Thomas O’Leary, Ph.D., Paula Amato, M.D., David Lee, M.D., Diana Wu, M.D., Sacha Krieg, M.D., Ph.D., Pamela B. Parker, M.D., M.P.H.
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	F&S Reports
Subjects:	Early pregnancy loss mifepristone in vitro fertilization embryo transfer
Online Access:	http://www.sciencedirect.com/science/article/pii/S266633412300003X

Similar Items

Management of early pregnancy loss by reproductive endocrinologists: does access to mifepristone matter?
by: Zachary S. Anderson, M.D., et al.
Published: (2024-09-01)

Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death
by: Damyanti Sharma, et al.
Published: (2011-09-01)

Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01)

Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01)

Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
by: John C. Parker, MD, et al.
Published: (2022-01-01)

Direct Effects of Mifepristone on Mice Embryogenesis: An In Vitro Evaluation by Single-Embryo RNA Sequencing Analysis
by: Yu-Ting Su, et al.
Published: (2023-03-01)

Induction of Labor Using Misoprostol With or Without Mifepristone in Intrauterine Deat
by: Ajay Agrawal, et al.
Published: (2014-06-01)

Mifepristone Directly Disrupts Mouse Embryonic Development in Terms of Cellular Proliferation and Maturation In Vitro
by: Yu-Ting Su, et al.
Published: (2021-11-01)

A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion
by: Nidhi Gupta, et al.
Published: (2023-10-01)

Partial Hydatidiform Mole in a Medical Abortion with the Mifepristone/Misoprostol Combination
by: Pui-Ki Chow, et al.
Published: (2004-12-01)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
by: Ellen R Wiebe, et al.
Published: (2020-01-01)

Different Time Schedules of Mifepristone and Misoprostol in Second Trimester Medical Abortion: A Comparative Study
by: Nalini Sharma, et al.
Published: (2017-07-01)

Monitoring Medical Abortion Using Mifepristone/Misoprostol Combination with Ultrasonogram and Serum Human Chorionic Gonadotropin
by: Szu-Yuan Chou, et al.
Published: (2006-03-01)

Role of Combination OF Mifepristone and Misoprostol Verses Misoprostol alone in Induction of Labour in Late Intrauterin Fetal Death: A Prospective Study.
by: Subrat Panda, et al.
Published: (2013-12-01)

Effect of mifepristone-misoprostol versus misoprostol in the management of intrauterine fetal death: A comparative study
by: T R Sindhuri, et al.
Published: (2020-01-01)

Embryo cryopreservation and utilization in the United States from 2004–2013
by: Mindy S. Christianson, M.D., et al.
Published: (2020-09-01)

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
by: Charlotte Hamel, et al.
Published: (2021-02-01)

Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
by: Yazhini Arjunan, et al.
Published: (2017-01-01)

Hepatitis B virus in oocytes and embryos: pregnancy outcomes and children’s health
by: Xiaoling Hu, Ph.D., et al.
Published: (2024-09-01)

To Study the Efficacy of Intraamniotic Prostaglandin F2 Alpha versus Mifepristone and Misoprostol Combination for Mid-trimester Medical Termination of Pregnancy
by: NM Anupam Kapur, et al.
Published: (2024-08-01)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
by: Ferid A. Abubeker, et al.
Published: (2020-07-01)

Efficacy of Mifepristone/Misoprostol Combination for Medical Abortion Determined by Detection of Retained Products in a Community Hospital in Taipei, Taiwan
by: Szu-Yuan Chou, et al.
Published: (2004-06-01)

Simulation-based training for embryo transfer for clinicians with differing levels of expertise: an application of the American Society for Reproductive Medicine Embryo Transfer Simulator
by: Katherine M. Baker, M.D., et al.
Published: (2023-03-01)

Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT
by: Adam Devall, et al.
Published: (2021-11-01)

Evaluation of a strategy for difficult embryo transfers from a prospective series of 2,046 transfers
by: Lionel Larue, M.D., Ph.D., et al.
Published: (2021-03-01)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
by: Tariku Shimels, et al.
Published: (2023-03-01)

Assessing the impact of semen quality on embryo development in an egg donation model
by: Lusine Aghajanova, M.D., Ph.D., et al.
Published: (2021-03-01)

Order from chaos: a case report of a healthy live birth from a genetically “chaotic” embryo
by: Joanna Lin, M.D., et al.
Published: (2022-12-01)

Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial)
by: Joyce van den Berg, et al.
Published: (2019-11-01)

Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation
by: Prakasit Saengbanyang, et al.
Published: (2024-09-01)

Patients with Recurrent Pregnancy Loss Have Similar Embryonic Preimplantation Genetic Testing Aneuploidy Rates and In Vitro Fertilization Outcomes to Infertility Patients
by: Molly Siegel Kornfield, M.D., et al.
Published: (2022-12-01)

Use of time-lapse technology on fertilization verification, embryo evaluation, and utilization: A national survey in JapanAJOG Global Reports at a Glance
by: Mitsutoshi Yamada, MD, PhD, et al.
Published: (2024-11-01)

Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments
by: Mohamed Afifi, et al.
Published: (2024-06-01)

Comparison of outpatient with inpatient mifepristone usage for cervical ripening: A randomised controlled trial
by: O. Baev, et al.
Published: (2023-06-01)

Cellular Effects of Naringin in Prevention of Genotoxicity Caused by Mifepristone on Human Blood Lymphocytes
by: Mohammad Shokrzadeh, et al.
Published: (2018-06-01)

The use of an embryo transfer simulator to compare transfer techniques and pregnancy outcomes among physicians
by: Dana B. McQueen, M.D., et al.
Published: (2024-06-01)

Anticancer effects of mifepristone on human uveal melanoma cells
by: Prisca Bustamante Alvarez, et al.
Published: (2021-11-01)

Fresh vs. frozen: pregnancy outcomes and treatment efficacy between fresh embryo transfer vs. untested freeze-all cycles
by: Zoran J. Pavlovic, M.D., et al.
Published: (2024-12-01)

Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
by: Shen Q, et al.
Published: (2019-09-01)